University of Pennsylvania researchers have developed a stem cell-based test to determine whether genetic variants in heart muscle cells are benign or pathogenic. In other words, they’ve added some certainty to variants of uncertain…

Receiving the flu vaccine could improve cardiovascular and all-cause mortality outcomes in patients with heart failure (HF), according to a large-scale study of Danish citizens published Dec. 10 in …

Researchers have grappled with the so-called “obesity paradox” for years. Some have found that a high bodyweight is…

Heart patients who suffer Takotsubo cardiomyopathy (TC) could face longer hospital stays, poorer outcomes and more than $150,000 in hospital bills if they’re undergoing chemotherapy simultaneously, researchers report in the…

Data presented at the 2018 EuroEcho-Imaging congress in Milan suggest breast cancer patients who take the common chemo drug trastuzumab might be able to mitigate their risk of heart damage by supplementing with carvedilol, a beta-…

Home telemonitoring approaches for heart failure patients are associated with lower odds of death at six months but not beyond that, according to a meta-analysis…

Seniors taking five or more prescription drugs to treat heart failure could be at an increased risk for functional impairment, according to a study published in the …

Using a biomarker target to guide the treatment of patients with heart failure with reduced ejection fraction (HFrEF) resulted in higher healthcare costs without significant improvements in quality of life compared to standard treatment,…

Results from a study published in the Journal of Women’s Health Nov. 27 suggest both miscarriages and a high number of births have a significant impact on women…

Scientists at the University of Oxford are pitching cardiologists a new model for heart regeneration research: the Mexican tetra fish, a blind, translucent animal with an innate ability to repair its damaged heart tissue.

The idea of “rapid and complete recovery” in Takotsubo patients is a myth, according to research published in the Nov. 7 edition of the European Heart Journal…

According to Brian P. Halliday, PhD, patients with recovered dilated cardiomyopathy often ask, “Do I need to continue to take these medications forever?”

They’re frequently young, so the prospect of using drugs for…

Sacubitril-valsartan therapy was associated with greater reductions in N-terminal pro-B-type natriuretic peptide (NT-proBNP) than enalapril among patients hospitalized with acute decompensated heart failure, according to research presented…

Poor health literacy could mean an increased risk of death for patients hospitalized with acute decompensated heart failure (ADHF), according to a study…

Inhibiting a certain class of cyclin-dependent kinase (CDK) proteins could protect cancer patients from chemotherapy-induced heart failure—the second leading cause of death in the demographic after cancer recurrence—according to…

Researchers have discovered a novel biomarker in stable, ambulatory patients with heart failure with preserved ejection fraction (HFpEF), a finding which may lead to earlier diagnoses of HFpEF.

The biomarker—called the…

Guideline-directed medical therapies (GDMTs) like beta-blockers and renin-angiotensin system blockers (RASBs)—but not aldosterone antagonists (AAs)—are associated with improved outcomes in heart failure patients hospitalized with a…

The National Institutes of Health (NIH) is pausing a taxpayer-funded, $63 million trial of cardiac stems cells over questions about the basis for the research.

Cardiologists and researchers had previously…

Cardiac transplant candidates are better off accepting an organ with a higher risk of transmitting diseases than waiting for another heart, suggests a study published Oct. 29 in the…

Omega-3 treatment was associated with significantly fewer gastrointestinal bleeding events for patients with left ventricular assist devices (LVADs), researchers reported in …

Higher ejection fractions (EFs) among heart failure patients are associated with an increased incidence of atrial fibrillation (AF) and worse cardiovascular outcomes, according to data from a multinational European registry.

Barak Zafrir…